Dr. Menon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1144 Eastlake Ave E, Seattle WA
Seattle, WA 98109Phone+1 855-557-0555
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2004 - 2007- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2002 - 2004
University of ConnecticutInternship, Internal Medicine, 2001 - 2002
Stanley Medical College SMCClass of 1999
Certifications & Licensure
ID State Medical License 2024 - 2025
WA State Medical License 2022 - 2025
WI State Medical License 2010 - 2023
MN State Medical License 2003 - 2012
TX State Medical License 2010 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
- Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
- Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
- Join now to see all
Publications & Presentations
PubMed
- 56 citationsBrigatinib in Patients With Alectinib-Refractory ALK-Positive NSCLCJessica J. Lin, Viola W. Zhu, Adam J. Schoenfeld, Beow Y. Yeap, Ashish Saxena
Journal of Thoracic Oncology. 2018-10-01 - 108 citationsAdvances in Cancer Immunotherapy in Solid Tumors.Smitha Menon, Sarah Shin, Grace K. Dy
Cancers. 2016-11-24 - 5 citationsAndrogen Mediation—and Antiandrogens Mitigation—of the Epidermal Growth Factor Receptor (EGFR) Inhibitor–Induced Rash: Results From a Pilot Randomized Trial and Small ...Jennifer Le-Rademacher, Kendrith M. Rowland, Pamela J. Atherton, Christopher S R Dakhil, Zhifu Sun
The American Journal of Hospice & Palliative Care. 2019-01-02
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
